Review: Free radicals, antioxidants, and the immune system

Annals of Clinical and Laboratory Science

Volumn 30, Issue 2, 2000, Pages 145-158

  Knight, Joseph A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Free radicals; Immune; Immunity; Lipid peroxidation; Oxidants

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAROTENOID; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; ISOPROSTANE; MYELOPEROXIDASE; NITRIC OXIDE; OXYGEN RADICAL; PEROXYNITRITE; PROSTAGLANDIN; SELENIUM; ZINC;

ANTIBODY RESPONSE; AUTOIMMUNITY; CALORIC RESTRICTION; HUMAN; IMMUNITY; LIPID PEROXIDATION; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RESPIRATORY BURST; REVIEW; VIRUS INFECTION;

ANIMALS; ANTIOXIDANTS; FREE RADICALS; HUMANS; IMMUNE SYSTEM; LIPID PEROXIDATION;

EID: 0034050669     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Good RA, Yunis E. Association of autoimmunity, immunodeficiency and aging in man, rabbits, and mice. Fed Proc 1974;33:2040-2050.
2. Meydani SN, Wu D, Santos MS, Hayek MG. Antioxidants and immune response in aged persons: Overview of present evidence. Am J Clin Nutr 1995;62(suppl):1465S-1476S.
3. Hatman LJ, Kayden HJ. A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood. J Lipid Res 1979;20:639-645.
4. Coquette A, Vray B, Vanderpas J. Role of vitamin E in the protection of the resident macrophage membrane against oxidative damage. Arch Int Physiol Biochim 1986;94:529-534.
5. Makinodan T, Kay MMB. Age influence on the immune system. Adv Immunol 1980;29:287-330.
6. Hirokawa K. Understanding the mechanism of the age-related decline in immune function. Nutr Rev 1992;50:361-366.
7. Kirwood TB, Ritter MA. The interface between ageing and health in man. Age Ageing 1997;26-S4: 9-14.
8. Wikby A, Johansson B, Fergunson F, Olsson J. Age-related changes in immune parameters in a very old population of Swedish people: A longitudinal study. Exp Gerontol 1994;5:531-541.
9. Nagel JE, Chrest FJ, Adler WH. Enumeration of T lymphocyte subsets by monoclonal antibodies in young and aged humans. J Immunol 1981;127: 2086-2088.
10. Gillis S, Kozak R, Durante M, Weksler ME. Immunological studies of aging: Decreased production of, and response to, T cell growth factor by lymphocytes from aged humans. J Clin Invest 1981;67:937-942.
11. Ershler WB, Sun WH, Binkley N et al. Interleukin-6 and aging: Blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 1993;12:225-230.
12. 2+] in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB J 1992;6:919-924.
13. Ershler WB. Interleukin-6: A cytokine for gerontologists. J Am Geriatr Soc 1993;41:176-181.
14. Mysliwska J, Bryl E, Foester J, Myslinski A. Increase in interleukin 6 and decrease in interleukin 2 production during the ageing process are influenced by the health status. Mech Ageing Dev 1998;100: 313-328.
15. Hirokawa K. Reversing and restoring immune functions. Mech Ageing Dev 1997;93:119-124.
16. Knight JA, Smith SE, Kinder VE, Anstall HB. Reference intervals for plasma lipoperoxides: Age-, sex-, and specimen-related variations. Clin Chem 1987;33:2289-2291.
17. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994;91:10771-10778.
18. Harman D. Aging: Prospects for further increases in the functional life span. Age 1994;17:119-146.
19. Mezzetti A, Lapenna D, Romano F et al. Systemic oxidative stress and its relationship with age and illness. J Am Geriatr Soc 1996;44:823-827.
20. Kumar V, Cotran RS, Robbins SL. Acute and chronic inflammation. In: Basic Pathology, WB Saunders Co., Philadelphia, 1992; p 31.
21. Silverstein SC, Steinman RM, Cohn ZA. Endocytosis. Ann Rev Biochem 1977;46:669-722.
22. Babior BM. Oxidants from phagocytes: Agents of defense and destruction. Blood 1984;64:959-966.
23. Babior BM. The respiratory burst of leukocytes. J Clin Invest 1984;73:599-601.
24. Knight JA. The aging process. In: Free Radicals, Antioxidants, Aging, and Disease. AACC Press, Washington, DC, 1999; p. 64.
25. Winrow VR, Winyard PG, Morris CJ, Blake DR. Free radicals in inflammation: Second messengers and mediators of tissue destruction. Br Med Bull 1993;49:506-522.
26. Mandell GL. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun 1974;9:337-341.
27. Patino PJ, Peres JE, Lopez JA et al. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox. Hum Mutat 1999;13:29-37.
28. Gallin JI, Malech HL. Update on chronic granulomatous disease of childhood. J Am Med Assoc 1990;263:1533-1537.
29. Selvaraj RJ, Sbarra AJ. Relationship of glycolytic and oxidative metabolism to particle entry and destruction in phagocytosing cells. Nature 1966; 211:1272-1276.
30. Segal AW. Variations on the theme of chronic granulomatous disease. Lancet 1985;1:1378-1383.
31. 2-independent bactericidal system. J Clin Invest 1985;69:959-970.
32. Young JD-E, Peterson CGB, Venge P, Cohn ZA. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986;321:613-616.
33. Anggard E. Nitric oxide: Mediator, murderer, and medicine. Lancet 1994;343:199-206.
34. Ischiropoulos H, Zhu L, Chen J et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431-437.
35. Viner RI, Ferrington DA, Huhmer AFR et al. Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca-ATPase of rat skeletal muscle during aging: A peroxynitrite-mediated process? FEBS Lett 1996;377:286-290.
36. Zhu L, Gunn C, Beckman JS. Bactericidal activity of peroxynitrite. Arch Biochem Biophys 1992;298: 452-457.
37. Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992;298:446-451.
38. Gregory SH, Wing EJ, Huffman RA, Simmons RL. Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol 1993;150:2901-2909.
39. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
40. Nathan CF, Hibbs JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991;3:65-70.
41. Knight JA. Free radicals: their presence in biological systems. In: Free Radicals, Antioxidants, Aging, and Disease. Amer Assn Clin Chem Press, Washington, DC, 1999; pp 1-31.
42. Eze MO. Membrane fluidity, reactive oxygen species, and cell-mediated immunity: Implications in nutrition and disease. Med Hypoth 1992;37: 220-224.
43. Umeki S, Sumi M, Niki Y, Soejima R. Concentrations of superoxide dismutase and superoxide anion in blood of patients with respiratory infection and compromised immune system. Clin Chem 1987;33:2230-2233.
44. Yasmineh WG, Kaur TP, Blazer BR, Theologides A. Serum catalase as a marker of graft-vs-host disease in allogeneic bone marrow transplant recipients: A pilot study. Clin Chem 1995;41:1574-1580.
45. Bogden JD, Bendich A, Kemp FW et al. Daily micronutrient supplements enhance delayed-hypersensitivity skin test responses in older people. Am J Clin Nutr 1994;60:337-347.
46. Fidelus RK, Tsan M-F. Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen. Cell Immunol 1986;97:155-163.
47. Smyth MJ. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J Immunol 1991;146:1921-1927.
48. Yim C-Y, Hibbs JB, McGregor JR et al. Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J Immunol 1994;152:5796-5805.
49. Flohe L, Hecht HJ, Steinert P. Glutathione and trypanothione in parasitic hydroperoxide metabolism. Free Radic Biol Med 1999;27:966-984.
50. Chandra RK. Nutrition and the immune system: An introduction. Am J Clin Nutr 1997;66:4605-463S.
51. Ceballos-Picot I, Trivier J-M, Nicole A et al. Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem 1992;38:66-70.
52. Dardenne M, Boukaiba N, Gagnerault M-C et al. Restoration of the thymus in aging mice by in vivo zinc supplementation. Clin Immunol Immunopathol 1993;66:127-135.
53. Keenan JM, Morris DH. How to make sure your older patients are getting enough zinc. Geriatrics 1993;48:57-65.
54. Duchateau J, Delepesse G, Vrijens R, Collet H. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med 1981;70:1001-1004.
55. Fortes C, Forastiere F, Agabiti N et al. The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc 1998;46:19-26.
56. Sazawal S, Black RE, Bhan MK et al. Zinc supplementation in young children with acute diarrhea in India. N Engl J Med 1995;333:839-844.
57. Mitchell GF. T cell dependent effects in parasite infection and disease. Prog Immunol 1980;4:794-808.
58. Chaudiere J, Wilhelmsen EC, Tappel EL. Mechanism of selenium glutathione peroxidase and its inhibition by mercaptocarnoxylic acids and other mercaptans. J Biol Chem 1984;259:1043-1050.
59. Berr C, Nicole A, Godin J et al. Selenium and oxygen-metabolizing enzymes in elderly community residents. A pilot epidemiological study. J Am Geriatr Soc 1993;41:143-148.
60. Beck MA. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice. Biomed Environ Sci 1997;10:307-315.
61. Beck MA. Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency. J Nutr 1997;127:9665-9705.
62. Beck MA. The influence of antioxidant nutrients on viral infection. Nutr Rev 1998;56:5140-5146.
63. Meeker HC, Eskew ME, Scheuchenzuber W et al. Antioxidant effects on cell-mediated immunity. J Leuk Biol 1985;38:451-458.
64. Sun E, Xu H, Liu Q et al. The mechanisms for the effect of selenium supplementation on immunity. Biol Trace Elem Res 1995;48:231-238.
65. Meydani SN, Haytek M. Vitamin E and the immune response. In: International Conference on Nutrition, Immunity, and Illness in the Elderly (Chandra RK, Ed), ARTS Biomedical Publ, St. Johns, Newfoundland, 1992; pp 105-128.
66. Meydani SN, Barklund MP, Liu S et al. Vitamin E supplementation enhances cell-mediated immunity in healthy subjects. Am J Clin Nutr 1990;52: 557-563.
67. Meydani SN, Meydani M, Blumberg JB et al. Vitamin E supplementation enhances in vivo immune response in healthy elderly: A dose-response study. J Am Med Assoc 1997;277:1380-1386.
68. Schmidt K. Antioxidant vitamins and beta-carotene: Effects on immunocompetence. Am J Clin Nutr 1991;53:383S-385S.
69. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sei USA 1991;88:11003-11006.
70. Niki E. Interaction of ascorbate and alpha-tocopherol. Ann NY Acad Sci 1987;498:186-199.
71. Harats D, Chevion S, Nahir M et al. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: Presumptive evidence for an interaction between vitamins C and E in vivo. Am J Clin Nutr 1998;67:240-245.
72. Anderson R, Lukey PT. A biological role for ascorbate in the selective neutralization of extracellular phagocyte-derived oxidants. Ann NY Acad Sci 1987;498:229-233.
73. Degkwitz E. Some effects of vitamin C may be indirect, since it affects the blood levels of cortisol and thyroid hormones. Ann NY Acad Sci 1987;498;470-472
74. Roth JA, Kaeberle ML. In vivo effect of ascorbic acid on neutrophil function in healthy and dexamethasone-treated cattle. Am J Vet Res 1985;46:2434-2436.
75. Gross WB, Jones D, Cherry J. Effect of ascorbic acid on the disease caused by Escherichia coli challenge infections. Avian Dis 1988;32:407-409.
76. Palozza P, Krinsky NI. Antioxidant effects of carotenoids in vivo and in vitro: An overview. In: Methods in Enzymology, Carotenoids (Packer L, Ed), Academic Press, San Diego, 1992; pp 403-439.
77. Chew BP. Role of carotenoids in the immune response. J Dairy Sci 1993;76:2804-2811.
78. Alexander M, Newmark H, Miller RG. Oral beta-carotene can increase the number of OKT4+ cells in human blood. Immunol Lett 1985;9:221-224.
79. Fuller CJ, Faulkner H, Bendich A et al. Effect of beta-carotene supplementation on photosuppression of delayed-type hypersensitivity in normal young men. Am J Clin Nutr 1992;56:684-690.
80. Penn ND, Purkins I, Kelleher J et al. The effect of dietary supplementation with vitamins A, C, and E on cell-mediated immune function in elderly long-stay patients: A randomized controlled study. Age Ageing 1991;20:169-174.
81. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly patients. Lancet 1992;340:1124-1127.
82. Bogden JD, Bendich A, Kempt FW et al. Daily micronutrient supplements enhance delayed-hypersensitivity skin test responses in older people. Am J Clin Nutr 1994;60:337-347.
83. Lesourd BM. Nutrition and immunity in the elderly: Modification of immune responses with nutritional treatments. Am J Clin Nutr 1997;66:478S-484S.
84. Meydani SN, Wu D, Santos MS, Hayek MG. Antioxidants and immune response in aged persons: Overview of present evidence. Am J Clin Nutr 1995;62(suppl):1462S-1476S.
85. Yu BP, Masoro EJ, McMahan CA. Nutritional influences on aging of Fischer 344 rats: I. Physical, metabolic, and longevity characteristics. J Gerontol 1985;40:657-670.
86. Knight JA. The aging process. In: Free Radicals, Antioxidants, Aging, and Disease, AACC Press, Washington, DC, 1999, pp 59-61.
87. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996;273:59-63.
88. Weindruch RH, Kristie JA, Cheney KE, Walford RL. Influence of controlled dietary restriction on immunologic function and aging. Fed Proc 1979;38:2007-2016.
89. Spear-Hartley A, Sherman AR. Food restriction and the immune system. J Nutr Immunol 1994;3: 27-50.
90. Kim M-J, Aiken JM, Havighurst T et al. Adult-onset energy restriction of Rhesus monkeys attenuates oxidative stress-induced cytokine expression by peripheral blood mononuclear cells. J Nutr 1997;127:2293-2301.
91. Spaulding CC, Walford RL, Effros RB. Caloric restriction inhibits the age-related dysregulation of the cytokines TNF-alpha and IL-6 in C3B10RF1 mice. Mech Ageing Dev 1997;93:87-94.
92. Belding ME, Klebanoff SJ, Ray CG. Peroxidase-mediated virucidal systems. Science 1970;167: 195-196.
93. Semba RD. Vitamin A, immunity and infection. Clin Infect Dis 1994;19:489-499.
94. Peterhans E. Oxidants and antioxidants in viral diseases: Disease mechanisms and metabolic regulation. J Nutr 1997;127:9625-9655.
95. Baier-Bitterlich G, Fuchs D, Wachter H. Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Biochem Pharmacol 1997;53: 755-763.
96. Semba RD. Vitamin A, immunity and infection. Clin Infect Dis 1994;19:489-499.
97. De-Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 1997;10: 1535-1541.
98. Chochola J, Strosberg AD, Stanislawski M. Release of hydrogen peroxide from human T cell lines and normal lymphocytes co-infected with HIV-1 and mycoplasma. Free Rad Res Comms 1995;23: 197-212.
99. Allard JP, Aghdassi E, Chau J et al. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998;67: 143-147.
100. Wang Y, Watson RR. Is vitamin E supplementation a useful agent in AIDS therapy? Prog Food Nutr Sci 1993;17:351-375.
101. Weimann BJ, Weiser H. Effects of antioxidant vitamins C, E, and beta-carotene on immune functions in MRL/lpr mice and rats. Ann NY Acad Sci 1992;669:390-392.
102. Gershwin ME, Lentz DR, Beach RS, Hurley LS. Nutritional factors and autoimmunity. J Immunol 1984;133:222-226.
103. Halliwell B, Gutteridge JMC. The importance of free radicals and catalytic metal ions in human diseases. Molec Aspects Med 1985;8:89-93.
104. Burkhardt H, Schwingel M, Menninger H et al. Oxygen radicals as effectors of cartilage destruction. Arthritis Rheum 1986;29:379-387.
105. Lunec J, Blake DR, McCleary SJ et al. Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest 1985;76:2084-2090.
106. Blake DR, Hall ND, Treby DA et al. Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci 1981;61:483-486.
107. Senator GB, Muirden KD. Concentration of iron in synovial fluid, and serum in rheumatoid arthritis and other joint diseases. Ann Rheum Dis 1968;27:49-53.
108. Biemond P, Swaak AJG, van EiJk HG, Koster JF. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic Biol Med 1988;4:185-188.
109. Biemond P, van Eijk HG, Swaak AJG, Koster JF. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: Possible mechanisms in inflammatory diseases. J Clin Invest 1984;73:1576-1579.
110. Gutteridge JMC. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 1986;201: 291-295.
111. Biemond P, Swaak AJG, Beindorff CM, Koster JF. Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Biochem J 1986;239:169-173.
112. Weinberg JB, Granger DL, Pisetsky DS et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monoethyl-L-arginine. J Exp Med 1994;179:651-660.
113. Weinberg JB, Gilkeson GS, Mason RP, Chamulitrat W. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice. Free Radic Biol Med 1998;24:191-196.
114. Hilliquin P, Borderie D, Hemvann A et al. Nitric oxide as S-nitrosoproteins in rheumatoid arthritis. Arthritis Rheum 1997;40:1512-1517.
115. Morrow JD, Hill KE, Burk RF et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-calalyzed mechanism. Proc Natl Acad Sci USA, 1990;87:9383-9397.
116. Rokach J, Khanapure SP, Hwang SW et al. The isoprostanes: A perspective. Prostaglandins 1997;54:823-851.
117. Liu T-Z, Stern A, Morrow JD. The isoprostanes: Unique bioactive products of lipid peroxidation. J Biomed Sci 1998;5:415-420.
118. Beharka AA, Wu D, Han SN, Meydani SN. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E. Mech Ageing Dev 1997;93:59-77.
119. Brennan FM, Maini RN, Feldman M. Cytokine expression in chronic inflammatory disease. Br Med Bull 1995;51:368-384.
120. Papavassiliou AG. Transcription factors. N Engl J Med 1995;332:45-47.
121. Baldwin AS Jr. The NF-κB and I-κB proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-683.
122. Barnes PJ, Karin M. Nuclear factor-κB: pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
123. Israel A. Ik B kinase all zipped up. Nature 1997;388:519-521.
124. Wang S, Leonard SS, Castranova V, Vallyathan V, Shi X. The role of superoxide radical in TNF-alpha-induced NF-κB activation. Ann Clin Lab Sci 1999;29:192-199.
125. Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation. Mol Cell Biol 1993;13:3301-3310.
126. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141-179.
127. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-720.
128. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999;45:7-17.